← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 20, 2020Last known activity
Jan 1, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (15 distinct, 11 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (23)
- NCT07272967Lead sponsorPhase 4Jan 1, 2026
- NCT07272967Sponsor investigatorPhase 4Jan 1, 2026
- NCT07296146Sponsor investigatorPhase 3Dec 15, 2025
- NCT07296146Lead sponsorPhase 3Dec 15, 2025
- NCT07180745Lead sponsorPhase 4Nov 1, 2025
- NCT07180745Sponsor investigatorPhase 4Nov 1, 2025
- NCT07102186Sponsor investigatorPhase 4Jul 21, 2025
- NCT07102186Lead sponsorPhase 4Jul 21, 2025
- NCT06510673CollaboratorN/AOct 1, 2024
- NCT06657079CollaboratorPhase 1/Phase 2May 1, 2024
- NCT06078449Reponsible party - principal investigatorN/ANov 11, 2023
- NCT06078449Lead sponsorN/ANov 11, 2023
- NCT06114381Sponsor investigatorN/AJan 1, 2023
- NCT06114381Reponsible party - principal investigatorN/AJan 1, 2023
- NCT06114381Lead sponsorN/AJan 1, 2023
Details
- Last known activity
- Jan 1, 2026